Cell-based assays have become increasingly important in the preclinical studies for biopharmaceutical products such as specialty peptides, which are of interest owing to their high substrate ...
SAN FRANCISCO, May 19, 2026 /PRNewswire/ -- Matter Bio today announced the submission of its first Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for ...
N-protein glycosylation is a post-translational modification that is conserved in all domains of life 1,2,3,4,5,6,7. The addition of a glycan to a protein can profoundly affect its structure, function ...
FDA clearance enables initiation of first-in-human Phase 1/2a clinical trial evaluating LM-LLO-TT, Matter Bio's attenuated Listeria monocytogenes-based immunotherapy candidate. The FDA clearance ...
Investigation of pegargiminase targeting the Fanconi anemia pathway and its role in DNA double-strand breaks induced by melphalan in uveal melanoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results